Published in Pathol Biol (Paris) on August 25, 1971
Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol (1997) 5.91
Swarming of Pseudomonas aeruginosa is dependent on cell-to-cell signaling and requires flagella and pili. J Bacteriol (2000) 4.59
Determinants of efficacy and toxicity of aminoglycosides. J Antimicrob Chemother (1989) 2.30
Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group. AIDS (2000) 2.04
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa. J Bacteriol (1999) 1.96
In-vitro activity of newer quinolones against aerobic bacteria. J Antimicrob Chemother (1986) 1.71
Pyogenic and tuberculous spondylodiskitis (vertebral osteomyelitis) in 80 adult patients. Clin Infect Dis (1994) 1.69
Activity of ten antimicrobial agents against anaerobic bacteria. J Antimicrob Chemother (1978) 1.66
Cellular events and intracellular survival of Campylobacter jejuni during infection of HEp-2 cells. Infect Immun (1989) 1.65
Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.62
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrob Agents Chemother (1987) 1.62
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. Antimicrob Agents Chemother (1988) 1.61
Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology (1990) 1.61
A plasmid-mediated cephalosporinase from Achromobacter species. J Infect Dis (1982) 1.55
Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae. Antimicrob Agents Chemother (1987) 1.55
Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents. Antimicrob Agents Chemother (1986) 1.52
Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft. J Vasc Surg (1994) 1.51
Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group. J Infect Dis (1995) 1.51
Toxoplasma colitis in the acquired immunodeficiency syndrome. Am J Gastroenterol (1992) 1.46
High risk of HIV disease progression after infection through a sexual partner with AIDS. AIDS (1996) 1.45
Occurrence of acute hepatitis A in patients infected with human immunodeficiency virus. Clin Infect Dis (2000) 1.45
Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin. Microb Pathog (1990) 1.42
Antibiotic prophylaxis of late bacteremic vascular graft infection in a dog model. Ann Vasc Surg (1990) 1.41
[Zona in 50 patients infected by human immunodeficiency virus. Clinical manifestations and prognostic value]. Presse Med (1990) 1.40
Treatment of antibiotic-induced colitis by metronidazole. Lancet (1978) 1.40
Effect of motility and chemotaxis on the invasion of Salmonella typhimurium into HeLa cells. Microb Pathog (1990) 1.38
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy. J Antimicrob Chemother (2003) 1.33
Clinical and echocardiographic observations in pulmonary valve endocarditis. Am J Cardiol (1985) 1.33
Pan-European survey of patients' attitudes to antibiotics and antibiotic use. J Int Med Res (1996) 1.33
Identification of Campylobacter jejuni surface proteins that bind to Eucaryotic cells in vitro. Infect Immun (1990) 1.32
Hematuria and rectal bleeding in the child with Klippel and Trenaunay syndrome. Ann Surg (1976) 1.31
Use of the arbitrary primer polymerase chain reaction for investigating an outbreak of Clostridium difficile-associated diarrhea in AIDS patients. Eur J Clin Microbiol Infect Dis (1993) 1.30
Combination therapy: a way to limit emergence of resistance? Am J Med (1986) 1.30
Varicella in patients infected with the human immunodeficiency virus. Arch Dermatol (1990) 1.28
Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 1.27
Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1991) 1.24
Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis (2001) 1.22
Use of corticosteroids in glomerulonephritis related to infective endocarditis: three cases and review. Clin Infect Dis (1999) 1.21
Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis (1995) 1.20
Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae. Antimicrob Agents Chemother (1991) 1.16
Definite streptococcus bovis endocarditis: characteristics in 20 patients. Clin Microbiol Infect (2001) 1.14
Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate. J Antimicrob Chemother (1990) 1.13
Activity of A-56268 (TE-031), a new macrolide, against Toxoplasma gondii in mice. J Antimicrob Chemother (1988) 1.12
Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir. Antimicrob Agents Chemother (2000) 1.12
Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus. J Infect Dis (1993) 1.12
In vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii. Antimicrob Agents Chemother (1989) 1.10
Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr (1991) 1.09
Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice. Antimicrob Agents Chemother (1992) 1.07
Novel method for measurement of outer membrane permeability to new beta-lactams in intact Enterobacter cloacae cells. Antimicrob Agents Chemother (1991) 1.06
Effect of mucin on Campylobacter jejuni association and invasion on HEp-2 cells. Microb Pathog (1988) 1.05
Development of beta-lactam-resistant Enterobacter cloacae in mice. J Infect Dis (1987) 1.04
Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii. Antimicrob Agents Chemother (1994) 1.02
Investigation of a nosocomial outbreak of Clostridium difficile-associated diarrhoea among AIDS patients by random amplified polymorphic DNA (RAPD) assay. J Hosp Infect (1994) 1.02
Cytomegalovirus colitis in HIV-1-infected patients: a prospective research in 55 patients. AIDS (1994) 0.99
Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs. J Virol (1996) 0.99
Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis (2001) 0.99
In vitro and in vivo effects of doxycycline on Toxoplasma gondii. Antimicrob Agents Chemother (1990) 0.98
C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem. Antimicrob Agents Chemother (2001) 0.97
Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.96
Activity of minocycline against Toxoplasma gondii infection in mice. J Antimicrob Chemother (1991) 0.96
Bacterial antibiotic efflux systems of medical importance. Cell Mol Life Sci (1999) 0.95
Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species. Antimicrob Agents Chemother (1989) 0.95
Fish oil decreases natural resistance of mice to infection with Salmonella typhimurium. Metabolism (1992) 0.95
Primary cytomegalovirus infection associated with the onset of ulcerative colitis. Eur J Clin Microbiol Infect Dis (1993) 0.95
Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother (1980) 0.94
Genetic background of attenuated Salmonella typhimurium has profound influence on infection and cytokine patterns in human dendritic cells. J Leukoc Biol (2001) 0.94
Provirus copy number to predict disease progression in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis (1994) 0.93
Levels of pyrimethamine in serum and penetration into brain tissue in humans. AIDS (1992) 0.93
Respective role of polymorphonuclear leukocytes and their integrins (CD-11/18) in the local or systemic toxicity of lipopolysaccharide. J Leukoc Biol (1993) 0.93
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group. Control Clin Trials (1998) 0.93
[Serum, lymph node and testicular concentrations of penicillin in 31 healthy or syphilitic rabbits treated with penicillin]. Pathol Biol (Paris) (1971) 0.93
Arteether, a qinghaosu derivative, in toxoplasmosis. Trans R Soc Trop Med Hyg (1988) 0.91
Comparative study of the beta-lactamase activity found in Achromobacter. Can J Microbiol (1983) 0.91
Pseudomonas aeruginosa infection in human immunodeficiency virus infected patients. J Infect (1999) 0.91
Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients. Antimicrob Agents Chemother (1976) 0.90
Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg (1991) 0.90
Macrophage oxidative metabolism and intracellular Toxoplasma gondii. Microb Pathog (1989) 0.90
Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS. J Infect Dis (1991) 0.90
Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice. Antimicrob Agents Chemother (1995) 0.89
Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages. J Antimicrob Chemother (1990) 0.89
Newly documented antimicrobial activity of quinolones. Eur J Clin Microbiol Infect Dis (1991) 0.89
[Generalized, Norman-Landing type, GM1 gangliosidosis: study of a case diagnosed during the life of the patient]. Ann Pediatr (Paris) (1968) 0.89
Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis. Tuber Lung Dis (1994) 0.89
Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV? Tuber Lung Dis (1992) 0.88
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. J Antimicrob Chemother (1986) 0.87
Vancomycin-aminoglycoside combinations in therapy of endocarditis caused by Enterococcus species and Streptococcus bovis. Eur J Clin Microbiol Infect Dis (1990) 0.87
In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli. Infection (1994) 0.87
Usual and unusual antibacterial effects of quinolones. J Antimicrob Chemother (1990) 0.86
[Tuberculosis in patients infected with the human immunodeficiency virus. 30 cases]. Presse Med (1988) 0.86
[Severe infections and septicemia due to group B streptococci in adults. Report of 4 cases including 1 case of tricuspid endocarditis complicated by glomerulonephritis]. Sem Hop (1974) 0.86
Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi's sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J Infect Dis (1996) 0.86
[Aortic and mitral endocarditis caused by Haemophilus paraphrophilus with abscess of the aortic ring and cerebral embolism]. Arch Mal Coeur Vaiss (1989) 0.85
Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study. Drugs (1988) 0.85
Ruptured mycotic pulmonary artery aneurysm: an unusual complication of right-sided endocarditis. Scand J Infect Dis (1998) 0.84
Two cases of cytomegalovirus infection revealed by hearing loss in HIV-infected patients. Biomed Pharmacother (1997) 0.84
[Erysipelothrix rhusiopathiae endocarditis. A case report and review of the literature]. Ann Med Interne (Paris) (1983) 0.84
High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome. Clin Exp Immunol (2000) 0.84